<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>92(13)</volume><submitter>Trenkwalder C</submitter><pubmed_abstract>OBJECTIVE:To investigate whether increased fixed carbidopa doses of 65 or 105 mg (ODM-101/65 and ODM-101/105) in combination with 75, 100, 125, or 150 mg of levodopa and 200 mg of entacapone might improve "off" time in fluctuating Parkinson disease (PD) compared to the standard combination of 4:1 levodopa/carbidopa with the usual 200 mg of entacapone (LCE) during a 4-week treatment period. METHODS:This was a randomized, double-blind, double-dummy, active-controlled, crossover, multicenter, phase II, proof-of-concept study in patients with fluctuating PD. RESULTS:One hundred seventeen patients were randomized into the study (mean age 67.0 years; daily "off" time 5.3 hours; mean daily levodopa dose 610 mg). Carryover-adjusted mean changes from baseline "off" times were during ODM-101/65, -1.</pubmed_abstract><journal>Neurology</journal><pagination>e1487-e1496</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6453771</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Increased dose of carbidopa with levodopa and entacapone improves "off" time in a randomized trial.</pubmed_title><pmcid>PMC6453771</pmcid><pubmed_authors>Vahteristo M</pubmed_authors><pubmed_authors>Ellmen J</pubmed_authors><pubmed_authors>Trenkwalder C</pubmed_authors><pubmed_authors>Kuoppamaki M</pubmed_authors><pubmed_authors>Muller T</pubmed_authors></additional><is_claimable>false</is_claimable><name>Increased dose of carbidopa with levodopa and entacapone improves "off" time in a randomized trial.</name><description>OBJECTIVE:To investigate whether increased fixed carbidopa doses of 65 or 105 mg (ODM-101/65 and ODM-101/105) in combination with 75, 100, 125, or 150 mg of levodopa and 200 mg of entacapone might improve "off" time in fluctuating Parkinson disease (PD) compared to the standard combination of 4:1 levodopa/carbidopa with the usual 200 mg of entacapone (LCE) during a 4-week treatment period. METHODS:This was a randomized, double-blind, double-dummy, active-controlled, crossover, multicenter, phase II, proof-of-concept study in patients with fluctuating PD. RESULTS:One hundred seventeen patients were randomized into the study (mean age 67.0 years; daily "off" time 5.3 hours; mean daily levodopa dose 610 mg). Carryover-adjusted mean changes from baseline "off" times were during ODM-101/65, -1.</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Mar</publication><modification>2025-04-04T23:59:36.007Z</modification><creation>2019-06-06T22:54:47Z</creation></dates><accession>S-EPMC6453771</accession><cross_references><pubmed>30824559</pubmed><doi>10.1212/WNL.0000000000007173</doi></cross_references></HashMap>